Gut Bacteria Linked With Long COVID Gut Bacteria Linked With Long COVID
' To our knowledge, this is the first study to show that altered gut microbiome is strongly associated with persistent symptoms in patients with COVID up to 6 months after clearance of SARS-CoV-2 virus. 'Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - January 25, 2022 Category: Internal Medicine Tags: Infectious Diseases News Source Type: news

Johnson & Johnson Reports Q4 and Full-Year 2021 Results
New Brunswick, N.J. (January 25, 2022) – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2021. “Our 2021 performance reflects continued strength across all segments of our business. Guided by Our Credo, I am honored to assume the role of CEO, leading our global teams in continuing our work to deliver life-changing solutions to consumers, patients, and health care providers” said Joaquin Duato, Chief Executive Officer. “Given our strong results, financial profile, and innovative pipeline we are well positioned for success in 2022 and beyond.” OVERALL F...
Source: Johnson and Johnson - January 25, 2022 Category: Pharmaceuticals Tags: Financial Source Type: news

Vaccination, Previous Infection Protect Against COVID-19
MONDAY, Jan. 24, 2022 -- Vaccination and previous COVID-19 infection were protective against COVID-19 infection and hospitalization during the alpha and delta severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) waves, according to research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 24, 2022 Category: Pharmaceuticals Source Type: news

Even Mild Covid-19 Can Cause Brain Dysfunction And Cognitive Issues
The research provides new clues as to why some people with long Covid experience long-term cognitive issues after being infected with the SARS-CoV-2 coronavirus. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 24, 2022 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Editors' Pick editors-pick Coronavirus business pharma & Source Type: news

The Olympics Will be the Ultimate Test for China ’s Zero-COVID Policy
Hosting the Olympic Games is a daunting challenge during any year. Add a global pandemic, and the logistics of welcoming the world’s athletes in while keeping the virus out become complicated fast. But China believes its aggressive stance against COVID-19 is up to the task. While the rest of the world is struggling to keep up with the virus, China’s strategy is to stay ahead of it. With its so-called “dynamic zero-COVID-19” policy, health officials try to contain any new cases by quickly testing, contact tracing, isolating and instituting lockdowns that block the spread of the virus. China’s p...
Source: TIME: Health - January 24, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 feature healthscienceclimate Magazine Source Type: news

Impact of COVID-19-related Public Health Measures on HCV Testing Impact of COVID-19-related Public Health Measures on HCV Testing
What impact did public health measures introduced to limit transmission of SARS-CoV-2 have on HCV testing and the HCV care cascade?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 24, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Pfizer and BioNTech publish data from two laboratory studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication of new results from two laboratory studies demonstrating that three doses of the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) elicited antibodies that neutralize the Omicron variant (B.1.1.529). (Source: World Pharma News)
Source: World Pharma News - January 24, 2022 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

Long COVID Associated With Risk of Metabolic Liver Disease Long COVID Associated With Risk of Metabolic Liver Disease
Postacute COVID syndrome, an ongoing inflammatory state following infection with SARS-CoV-2, is associated with greater risk of metabolic-associated fatty liver disease.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - January 22, 2022 Category: Gastroenterology Tags: Infectious Diseases News Source Type: news

COVID May Affect Spinal Fluid, Causing'Brain Fog,' Study Says COVID May Affect Spinal Fluid, Causing'Brain Fog,' Study Says
Researchers at the University of California, San Francisco, found abnormalities in the cerebrospinal fluid of 10 of 13 people who were infected with SARS-CoV-2 and had thinking problems.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - January 21, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Insights & Outcomes: Tick tendencies and some stretchy cell membranes
This month, Insights& Outcomes winds its way through tick proteins, antibodies that fight the SARS-CoV-2 virus, stretchy cell membranes, and more. (Source: Yale Science and Health News)
Source: Yale Science and Health News - January 21, 2022 Category: Universities & Medical Training Source Type: news

EARLY RELEASE: Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
This report describes COVID-19 vaccine effectiveness time frames among people who received their first and second doses of the vaccine series, and effectiveness of third vaccine doses during both Delta- and Omicron-predominant periods. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 21, 2022 Category: American Health Tags: Adult Health Coronavirus [CoV] Hospitalization rates MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Vaccination Vaccines COVID-19 Source Type: news

EARLY RELEASE: COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021
This report describes COVID-19 incidence rate ratios for unvaccinated versus fully vaccinated persons with and without booster vaccine doses during the emergence of the Omicron variant. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 21, 2022 Category: American Health Tags: Adult Health Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Vaccination Vaccines Death Rates COVID-19 Source Type: news

Ergonomic exposures and control measures associated with mass fatality decedent handling in morgues and body collection points in a New York healthcare system during COVID-19: a case series - Lee T, Sembajwe G, Dropkin J, Power P, Roy A.
INTRODUCTION: In April 2020, novel coronavirus SARS-Co-V-2 (COVID-19) produced an ongoing mass fatality event in New York. This overwhelmed hospital morgues necessitating emergent expansion of capacity in the form of refrigerated trucks, trailers, and ship... (Source: SafetyLit)
Source: SafetyLit - January 21, 2022 Category: International Medicine & Public Health Tags: Disaster Preparedness Source Type: news

Risk Factors for SARS-CoV-2 Among US Healthcare Personnel Risk Factors for SARS-CoV-2 Among US Healthcare Personnel
How likely are healthcare workers to contract COVID-19? A new report identifies certain factors associated with the risk.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 21, 2022 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Notes from the Field: Early Evidence of the SARS-CoV-2 B.1.1.529 (Omicron) Variant in Community Wastewater - United States, November-December 2021
This report describes early evidence of the Omicron variant in community wastewater. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 20, 2022 Category: American Health Tags: Advanced Molecular Detection Community Health Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Water Treatment COVID-19 Source Type: news

Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021
This report describes updated recommendations from the ACIP to the use of Janssen mRNA COVID-19 vaccines. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 20, 2022 Category: American Health Tags: Advisory Committee on Immunization Practices (ACIP) Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Vaccination Vaccine Ingredients Vaccine Safety Vaccines COVID-19 Source Type: news

Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 - United States, March 2020-August 2021
This report describes racial and ethnic disparities in receiving medications for COVID-19 treatment. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 20, 2022 Category: American Health Tags: Coronavirus [CoV] Diseases & Conditions Health Disparities Medication Safety MMWR Morbidity Mortality Weekly Report Race and Ethnicity SARS (Severe acute respiratory syndrome) Treatment COVID-19 Source Type: news

Fourth Vaccine Dose May Up COVID-19 Immunity in Kidney Transplant Recipients
THURSDAY, Jan. 20, 2022 -- A fourth dose of an mRNA-based anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine may increase antispike immunoglobulin (Ig)G titers in kidney transplant recipients, according to a research letter... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 20, 2022 Category: Pharmaceuticals Source Type: news

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose, The Lancet
In a letter describing 7 infections (omicron variant) despite 3 vaccine doses (including at least two doses of an mRNA vaccine), the authors note a mild to moderate course of disease, and conclude 3 doses may still provide good protection against severe disease from this variant. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 20, 2022 Category: Consumer Health News Source Type: news

The World ’s Largest Vaccine Manufacturer Stumbled in 2021. Its CEO Bets He Can Still Help End COVID-19
Adar Poonawalla is no stranger to gambles. He owes his multibillion-dollar empire to a series of big bets that paid off handsomely. Cyrus Poonawalla, his father, made his own fortune on horses—and then multiplied it by making another bet in 1966: that he could make more money producing vaccines than he could on horse breeding and racing. He formed the Serum Institute of India (SII), which grew slowly for three decades, selling antivenoms and lifesaving vaccines for India. When Adar, then just 21, joined the company in 2001, he persuaded his father to dramatically ramp up production—wagering that they could fill...
Source: TIME: Health - January 20, 2022 Category: Consumer Health News Authors: Abhishyant Kidangoor Tags: Uncategorized biztech2030 COVID-19 Davos feature Magazine overnight Special Project Source Type: news

A vaccine to prevent all Covid is within reach. Here ’s how to grab it
What exactly is a pan-coronavirus vaccine? The term has become a catchall for both vaccines that could protect against any current and future SARS-CoV-2 variants and those that could also provide immunity against SARS, MERS and any other coronaviruses that might come along. Scientists have reason to be optimistic that either kind is possible. (Source: The Economic Times)
Source: The Economic Times - January 20, 2022 Category: Consumer Health News Source Type: news

Wearable air sampler detects personal exposure to SARS-CoV-2
The YSPH-developed device can help assess whether a person has been exposed to SARS-CoV-2 and could be especially helpful for workers in high-risk settings. (Source: Yale Science and Health News)
Source: Yale Science and Health News - January 19, 2022 Category: Universities & Medical Training Source Type: news

Major Protease Of SARS-CoV-2 Acts To Suppress Innate Immunity
In October 2020, researchers discovered that the SARS-CoV-2 nonstructural protein 5 (NSP5) suppresses innate immunity. This has key implications for Covid-19 drug development that have yet to be fully explored. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 19, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus business pharma & Source Type: news

Choosing the Right Nanoparticle Probe for SARS-CoV-2 Lateral Flow Assays
Performance-based pros and cons of common nanoparticle probes (Source: The Scientist)
Source: The Scientist - January 19, 2022 Category: Science Tags: The Marketplace Source Type: news

EARLY RELEASE: COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021
This report describes COVID-19 cases and hospitalizations by vaccination status and previous COVID-19 diagnosis before and after the Delta variant became predominant. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 19, 2022 Category: American Health Tags: Coronavirus [CoV] Immune system MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Vaccination Vaccines COVID-19 Source Type: news

Now that science has defanged Covid, it ’s time to get on with our lives | Devi Sridhar
As with any other ineradicable disease, prevention and treatment can be integrated into societyDelaying and preventing infection as much as possible through this pandemic was a worthwhile strategy. In early 2020, there were few treatments, limited testing and no vaccines. The costs of those lockdowns were big, but the effort to buy time paid off. In that time, science has transformed Covid from a deadly virus to a much less serious, nasty disease – one that is manageable at home, for the vast majority of those vaccinated. It has, largely, defanged it.But even as we have had success treating and preventing serious inf...
Source: Guardian Unlimited Science - January 19, 2022 Category: Science Authors: Devi Sridhar Tags: Coronavirus Infectious diseases Health Medical research Microbiology Science UK news Vaccines and immunisation Source Type: news

SARS-CoV-2 may cause fetal inflammation even in the absence of placental infection
Small NIH study contributes to understanding of COVID-19 during pregnancy. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - January 18, 2022 Category: American Health Source Type: news

Therapies for IBD and Risks for Adverse Outcomes of SARS-CoV-2 Therapies for IBD and Risks for Adverse Outcomes of SARS-CoV-2
This study investigated risk factors for adverse COVID-19 outcomes in a cohort of IBD patients. Do IBD medications pose additional risks to those infected with SARS-CoV-2?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 18, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Liberia: Multi-Partner Liberia-U.S. Collaboration Publishes Findings On the Presence of Covid - 19 Delta Variant During Surge in Reported Infections
[FrontPageAfrica] Monrovia -- In June 2021, Liberia experienced a surge of cases of infection with SARS-CoV-2, the virus that causes COVID-19. To investigate why, a team of scientists from Liberia and the United States conducted an indepth study of virus samples collected in the country. Not long after, on August 5, 2021, the Liberia Minister of Health announced that one of the dominant strains of SARS-CoV-2 circulating in the country had been identified as the delta variant. These important findings, based on the analysis of 146 virus (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 18, 2022 Category: African Health Source Type: news

Pfizer shares in vitro efficacy of novel COVID-19 oral treatment against omicron variant
Pfizer Inc. (NYSE: PFE) today shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), is maintained against the SARS-CoV-2 variant Omicron. Taken together, these in vitro studies suggest that PAXLOVID has the potential to maintain plasma concentrations many-fold times higher than the amount required to prevent Omicron from replicating in cells. (Source: World Pharma News)
Source: World Pharma News - January 18, 2022 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

Stempeutics gets DCGI nod for Phase 3 clinical trial on its product for treating COVID patients
Stempeucel exhibits potent immuno-modulatory and anti-inflammatory properties which could help in reducing the inflammation caused due to the cytokine storm elicited by the body's immune cells in response to SARS-CoV-2 (COVID-19) related infection in the lungs, Stempeutics said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 18, 2022 Category: Pharmaceuticals Source Type: news

Experimental Drug Targets COVID-19 From Two Angles Experimental Drug Targets COVID-19 From Two Angles
An experimental drug originally being developed to treat influenza is showing promise against SARS-CoV-2 and might defend against COVID-19 from two different directions, researchers said.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 17, 2022 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Many People Could Still Be Infectious After 5-Day Quarantine Many People Could Still Be Infectious After 5-Day Quarantine
After a 5-day quarantine, about a third of people infected with SARS-CoV-2 might still be infectious, according to new data.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 17, 2022 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Infection prevention and control for seasonal respiratory infections in health and care settings (including SARS-CoV-2) for winter 2021 to 2022, UKHSA (updated 17th January 2022)
This guidance is intended to prevent transmission of seasonal respiratory viral infections focussing on influenza, SARS-CoV-2, and respiratory syncytial virus (RSV) in health and care settings while continuing to support the recovery of services. 17 January 2022Updated to reflect change in isolation period in hospitals from 14 to 10 days for cases and contacts of cases of COVID-19. Changed wording around RPE to clarify. 21 December 2021'COVID-19: infection prevention and control for mental health and learning disability settings appendix'has been withdrawn. The UK IPC guidance addresses the needs of the mental health an...
Source: Current Awareness Service for Health (CASH) - January 17, 2022 Category: Consumer Health News Source Type: news

SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland, Nature medicine
Study found perinatal mortality rate for women who gave birth (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 17, 2022 Category: Consumer Health News Source Type: news

COVID-19 Severity Before and During Delta Predominance COVID-19 Severity Before and During Delta Predominance
Does the SARS-CoV-2 B.1.617.2 (Delta) variant cause more severe disease in adults than other variants?Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 17, 2022 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

Texas scientists ’ new Covid-19 vaccine is cheaper, easier to make and patent-free
Dr Maria Bottazzi says their vaccine, called Corbevax, is unique because they do not intend to patent itA new Covid-19 vaccine is being developed by Texas scientists using a decades-old conventional method that will make the production and distribution cheaper and more accessible for countries most affected by the pandemic and where new variants are likely to originate due to low inoculation rates.The team, led by Drs Peter Hotez and Maria Bottazzi from the Texas Children ’s Hospital Center for Vaccine Development at Baylor College of Medicine, has been developing vaccine prototypes for Sars and Mers since 2011, whic...
Source: Guardian Unlimited Science - January 15, 2022 Category: Science Authors: Erum Salam Tags: Texas Coronavirus Vaccines and immunisation US news World news Science Source Type: news

Fact check: The theory that SARS-CoV-2 is becoming milder
A look at the data that omicron is less severe. What does that mean for the future of SARS-CoV-2 — and the pandemic?(Image credit: Science Source) (Source: NPR Health and Science)
Source: NPR Health and Science - January 14, 2022 Category: Consumer Health News Authors: Michaeleen Doucleff Source Type: news

EARLY RELEASE: Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 - United States, March 2020-August 2021
This report describes racial and ethnic disparities in receiving medications for COVID-19 treatment. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 14, 2022 Category: American Health Tags: Coronavirus [CoV] Diseases & Conditions Health Disparities Medication Safety MMWR Morbidity Mortality Weekly Report Race and Ethnicity SARS (Severe acute respiratory syndrome) Treatment COVID-19 Source Type: news

3 Percent of Youth Testing Positive for COVID-19 in ED Have Severe Outcomes
FRIDAY, Jan. 14, 2022 -- Approximately 3 percent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive youth tested in emergency departments experience severe outcomes within two weeks of their index visit, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 14, 2022 Category: Pharmaceuticals Source Type: news

COVID-19 variants: genomically confirmed case numbers, UKHSA (updated 14th January 2022)
Genomically confirmed case numbers for SARS-CoV-2 variants of concern and variants under investigation. 14 January 2022Added data up to 12 January 2022. 7 January 2022Added data up to 5 January 2022. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 14, 2022 Category: Consumer Health News Source Type: news

Indirect effects of the covid-19 pandemic on childhood infection in England: population based observational study, BMJ
Study found range of behavioural changes (adoption of non-pharmacological interventions) and societal strategies (school closures, lockdowns, restricted travel) used to reduce transmission of SARS-CoV-2 also reduced admissions for common and severe childhood infections. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 14, 2022 Category: Consumer Health News Source Type: news

Research team finds new dual benefit mode of action for a drug candidate to fight COVID-19
A research team led by Prof. Stephan Ludwig, a virologist at the Institute of Virology at the University of Münster, has found a new dual attack mode of action while working on the development of a drug candidate against SARS-CoV-2 infections. This could constitute the basis for a broadly effective drug to fight COVID 19. (Source: World Pharma News)
Source: World Pharma News - January 14, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Fully Ready to Kill, Shockingly Unprepared to Save Lives
Credit: Albert Gonzalez Farran / UNAMIDBy Baher KamalMADRID, Jan 14 2022 (IPS) While absolutely ready to kill, with the biggest military powers spending in 2020 nearly two trillion US dollars on weapons, the world is shockingly unprepared to save the lives of millions of unarmed, innocent civilian victims of wars… and other man-made catastrophes. The military spending data come from the Stockholm International Peace Research Institute (SIPRI), which also reports that global nuclear arsenals grow as states continue to modernise, thus sharply increasing the dangers of an unimaginable number of victims of the most deva...
Source: IPS Inter Press Service - Health - January 14, 2022 Category: International Medicine & Public Health Authors: Baher Kamal Tags: Development & Aid Economy & Trade Global Global Governance Headlines Health Peace Poverty & SDGs TerraViva United Nations Source Type: news

SARS-CoV-2 Infections Linked to Large Public Gatherings SARS-CoV-2 Infections Linked to Large Public Gatherings
A better understanding of how SARS-CoV-2 infections occur after large public gatherings could help prevent future outbreaks.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 14, 2022 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Covid booster vaccine: Nine bodily reactions to the jab that protects you against Omicron
COVID booster vaccinations continue in the war against Omicron - the highly transmissible, yet less deadly mutant strain of SARS-CoV-2. Here are the bodily reactions you might get. (Source: Daily Express - Health)
Source: Daily Express - Health - January 13, 2022 Category: Consumer Health News Source Type: news

Covid booster vaccine: Four 'severe' reactions to watch out for – side effects
COVID booster vaccinations continue in the war against Omicron - the highly transmissible, yet less deadly mutant strain of SARS-CoV-2. Here are the bodily reactions you might get. (Source: Daily Express - Health)
Source: Daily Express - Health - January 13, 2022 Category: Consumer Health News Source Type: news

Notes from the Field: HIV Outbreak During the COVID-19 Pandemic Among Persons Who Inject Drugs - Kanawha County, West Virginia, 2019-2021
This report describes a Kanawha County HIV outbreak during the COVID-19 pandemic among people who inject drugs. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 13, 2022 Category: American Health Tags: Coronavirus [CoV] HIV/AIDS Injection Safety MMWR Morbidity & Mortality Weekly Report Outbreaks SARS (Severe acute respiratory syndrome) Substance Use and Abuse COVID-19 Source Type: news

Risk for Newly Diagnosed Diabetes 30 Days After SARS-CoV-2 Infection Among Persons Aged 18 years - United States, March 1, 2020-June 28, 2021
This report describes how children and adolescents were more likely to receive a new diabetes diagnosis after infection with SARS-CoV-2, the virus that causes COVID-19. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 13, 2022 Category: American Health Tags: Adolescent Health Children's Health Coronavirus [CoV] Diabetes MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Type 2 Diabetes COVID-19 Source Type: news

Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021
This report describes how effective Pfizer-BioNTech COVID-19 vaccination was against multisystem inflammatory syndrome in children (MIS-C). (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 13, 2022 Category: American Health Tags: Coronavirus [CoV] MMWR Morbidity & Mortality Weekly Report SARS (Severe acute respiratory syndrome) Vaccination Vaccine Safety Vaccines COVID-19 Source Type: news